Insulin resistance is the major determinant for microalbuminuria in severe hypertriglyceridemia: Implication for high-risk stratification

Internal Medicine

Volumn 47, Issue 12, 2008, Pages 1091-1097

  Lin, Chien Yu ^a   Chen, Ming Fong ^b   Lin, Lian Yu ^b   Liau, Chiau Suong ^b   Lee, Yuan Teh ^b   Su, Ta Chen ^b  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

HOMA IR; Hypertriglyceridemia; Microalbuminuria; OGTT

Indexed keywords

GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE MARKER; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; ALBUMINURIA; BLOOD; COHORT ANALYSIS; GLUCOSE TOLERANCE TEST; IMPAIRED GLUCOSE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FIBRINOLYSIS; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO; PREDIABETIC STATE; RISK FACTORS;

EID: 48049094798     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0696     Document Type: Article

References (40)

1. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213-219, 1996.
2. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 85: 37-45, 1992.
3. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97: 1029-1036, 1998.
4. Jones JD, Chambliss ML. Hypertriglyceridemia and coronary heart disease. Arch Fam Med 9: 189-190, 2000.
5. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
6. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 100: 96-102, 1999.
7. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet 351: 88-92, 1998.
8. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91: 284-290, 1995.
9. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 22: 1865-1870, 1999.
10. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360, 1984.
11. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157: 1413-1418, 1997.
12. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 23: 195-199, 1994.
13. Alzaid AA. Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 19: 79-89, 1996.
14. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226, 1989.
15. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol 15: 1324-1329, 1995.
16. Roest M, Banga JD, Janssen WM, et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103: 3057-3061, 2001.
17. Hillege HL, Fidler V, Diercks GFH, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782, 2002.
18. Expert Committee, on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (Suppl 1): S5-S20, 2003.
19. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study Diabetes Care 20: 1087-1092, 1997.
20. Chaiken RL, Khawaja R, Bard M, Eckert-Norton M, Banerji MA, Lebovitz HE. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care 20: 709-713, 1997.
21. Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH Publication No. 02-5215. National Heart, Lung, and Blood Institute, National Institutes of Health, 2002.
22. Ginsberg HN. New perspectives on atherogenesis: Role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 106: 2137-2142, 2002.
23. Reaven GM, Laws A, Eds. Insulin Resistance: The Metabolic Syndrome X. Human Press, Totowa, NJ, 1999.
24. Zavaroni IE, Bonora M, Pagliara E, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702-706, 1989.
25. Lundman P, Eriksson MJ, Stuhlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 38: 111-116, 2001.
26. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, et al. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: Reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol 20: 744-750, 2000.
27. Jonkers IJ, van de Ree MA, Smelt AH, et al. Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia. Cardiovasc Res 53: 496-501, 2002.
28. Criqui MH, Heiss G, Cohn R. et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328: 1220-1225, 1993.
29. Fujikawa R, Okubo M, Egusa G, Kohno N. Insulin resistance precedes the appearance of albuminuria in non-diabetic subsjects: 6 years follow-up study. Diab Res Clin Prac 53: 99-106, 2001.
30. Hochner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 13: 1626-1634, 2002.
31. Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 41: 694-700, 1998.
32. Hoffmann IS, Jimenez E, Cubeddu LX. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Human Hypertens 15: 407-412, 2001.
33. Toft I, Bonaa KH, Eikrem J, Bendiksen AL, Iversen H,Jenssen T. Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 61: 1445-1452, 2002.
34. Huang CL, Chen MF, Jeng JS, et al. Post-challenge hyperglycemic spike associate with arterial stiffness. Int J Clin Pract 61: 397-402, 2007.
35. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Post-challenge plasma glucose and glycemic spike are more strongly associated with atherosclerosis than fasting glucose or HbAlc level. Diabetes Care 23: 1830-1834, 2000.
36. Hanefeld M, Koehler C, Henkel E, Fueeker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycemia relates more strongly than fasting hyperglycaemia with carotid intimamedia thickness: the RIAD Study. Diabet Med 17: 835-840, 2000.
37. Qiao Q, Tuomilehto J, Borch-Johnsen K. Post-challenge hyperglycemia is associated with premature death and macrovascular complications. Diabetologia 46 (Suppl 1), M17-M21, 2003.
38. Lupattelli G, Lombardini R, Schillaci G, et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J 140: 521-526, 2000.
39. Hackman A, Abe Y, Insull W Jr, et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93: 1334-1338, 1996.
40. Per E, Lennart N, Fredirk K, Anders H. Very low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 18: 20-26, 1998.